MWNA
ESPR icon

Marshall Wace North America’s Esperion Therapeutics ESPR Stock Holding History

Marshall Wace North America’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.52M Buy
+125,953
New +$1.83M 0.01% 799
2021
Q2 		– Sell
-7,175
Closed -$201K – 1542
2021
Q1 		$201K Buy
+7,175
New +$212K ﹤0.01% 1408
2020
Q3 		– Sell
-19,763
Closed -$1.01M – 1282
2020
Q2 		$1.01M Buy
+19,763
New +$827K 0.01% 754
2020
Q1 		– Sell
-23,750
Closed -$1.42M – 1334
2019
Q4 		$1.42M Buy
+23,750
New +$1.07M 0.01% 649
2019
Q2 		– Sell
-4,091
Closed -$164K – 1274
2019
Q1 		$164K Buy
+4,091
New +$184K ﹤0.01% 1029
2013
Q4 		$201K Sell
14,615
-891
-6% -$13K ﹤0.01% 642
2013
Q3 		$292K Buy
+15,506
New +$260K 0.01% 519

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return